Sept 22 Reuters - U.S. Centers for Disease Control and Prevention advisory panel could vote on a third shot of Pfizer Inc and partner BioNTech SE's COVID - 19 vaccine on Thursday, an agency official said, while kick-off the two days panel discussion on Wednesday.
The CDC Advisory Committee on Immunization Practices ACIP is meeting on 22 and 23 September to discuss which Americans should get the third vaccination shot, should it be authorized by the Food and Drug Administration for use?
Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence to back up the shot for people over 65 and older. The FDA has not yet said what it wants to proceed.